CellSource Co (TSE:4880) Change In Inventory: 円-26 Mil (TTM As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4880 CellSource Co Ltd TSE:4880
70 GF Score
Price 円356.00
GF Value 円777.73
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is CellSource Co Change In Inventory?

CellSource Co TSE:4880 +1.42% 70 Change In Inventory is 円-26 Mil as of Apr. 2026. GuruFocus rates TSE:4880 with a GF Score™ of 70/100 and a GF Value™ of 円777.73 (Significantly Undervalued). The stock has 6 warning signs investors should review.

CellSource Co's change in inventory for the quarter that ended in Apr. 2026 was 円-41 Mil. It means CellSource Co's inventory increased by 円41 Mil from Oct. 2025 to Apr. 2026 .

CellSource Co's change in inventory for the fiscal year that ended in Oct. 2025 was 円18 Mil. It means CellSource Co's inventory declined by 円18 Mil from Oct. 2024 to Oct. 2025 .

CellSource Co's Total Inventories for the quarter that ended in Apr. 2026 was 円308 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. CellSource Co's Days Inventory for the quarter that ended in Apr. 2026 was 71.64.

Inventory Turnover measures how fast the company turns over its inventory within a year. CellSource Co's Inventory Turnover for the quarter that ended in Apr. 2026 was 2.55.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. CellSource Co's Inventory-to-Revenue for the quarter that ended in Apr. 2026 was 0.16.

CellSource Co  (TSE:4880) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

CellSource Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=286.892/730.822*365 / 2
=71.64

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

CellSource Co's Inventory Turnover for the quarter that ended in Apr. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=730.822 / 286.892
=2.55

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

CellSource Co's Inventory to Revenue for the quarter that ended in Apr. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=286.892 / 1775.588
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CellSource Co Change In Inventory Related Terms

CellSource Co Change In Inventory Historical Data

* Premium members only.

The historical data trend for CellSource Co's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CellSource Co Change In Inventory Chart

CellSource Co Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only -33.22 -61.48 -78.90 22.09 17.65

CellSource Co Semi-Annual Data
Oct17 Oct18 Oct19 Apr20 Oct20 Apr21 Oct21 Apr22 Oct22 Apr23 Oct23 Apr24 Oct24 Apr25 Oct25 Apr26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.05 -51.96 2.21 15.44 -41.42
TSE:4880
70GF Score
CellSource Co Ltd TSE:4880
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CellSource Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Apr. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円-26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of 円-26 Mil mean?
CellSource Co (TSE:4880) has a Change In Inventory of 円-26 Mil as of Apr. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for CellSource Co and its competitors.
Is CellSource Co's Change In Inventory too high?
CellSource Co's current Change In Inventory is 円-26 Mil. Overall, CellSource Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CellSource Co's Change In Inventory compare to VRTX and REGN?
CellSource Co's Change In Inventory of 円-26 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for CellSource Co and its competitors. CellSource Co's current Change In Inventory is 円-26 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CellSource Co stock overvalued right now?
Based on GuruFocus' analysis, CellSource Co (TSE:4880) is currently considered Significantly Undervalued. The stock's GF Value™ is 円777.73, compared to a current price of 円356.00 — trading 54.2% below its estimated fair value. The current Change In Inventory is 円-26 Mil. CellSource Co's overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For CellSource Co (TSE:4880), the current Change In Inventory is 円-26 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CellSource Co (TSE:4880) Overvalued in 2026?

Based on GuruFocus' analysis, CellSource Co stock appears to be undervalued. The current stock price of 円356.00 is trading 54.2% below its estimated GF Value™ of 円777.73. GuruFocus considers CellSource Co to be Significantly Undervalued.

Key valuation signals for TSE:4880:

  • Change In Inventory: 円-26 Mil
  • GF Value™: 円777.73 vs. price of 円356.00 (54.2% below fair value)
  • GF Score™: 70/100 with 6 warning signs

No single metric tells the full story. See the TSE:4880 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CellSource Co Business Description

Address Shibuya Mitake Building, 2nd Floor, 1-19-5 Shibuya, Shibuya-ku, Tokyo, JPN, 150-0002
CellSource Co Ltd is engaged in contract manufacturing of fat-and blood-derived organizations and cells from medical institutions, provision of legal support to medical institutions in the regenerative medicine business. The company is also involved in sales of medical devices, and sales of own-brand cosmetics in the consumer business.
70GF Score

Get the complete analysis for TSE:4880

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円356.00
Price
円777.73
GF Value